You are here: Companies > Viralytics Limited (VLA) > Final data from Phase 2 Clinical Trial

Viralytics Limited (VLA)

Final data from Phase 2 Clinical Trial

17 June 2015 - CEO : Dr. Malcolm McColl

ASCO Presentation of Phase 2 CALM Clinical Trial Results